期刊文献+

TGF-β1和p21WAF1在中耳胆脂瘤中的表达及其意义 被引量:2

Expressions of TGF-β1 and p21WAF1 in middle ear cholesteatoma and their significances
下载PDF
导出
摘要 目的:探讨TGF-β1和p21WAF1在中耳胆脂瘤中的表达,了解两者在胆脂瘤发病中的作用。方法:应用免疫组化技术检测20例中耳胆脂瘤组和10例正常对照组中TGF-β1和p21WAF1的表达。结果:①p21WAF1定位于细胞核,呈棕黄色颗粒状;TGF-β1主要胞浆着色,呈棕黄色颗粒状。②中耳胆脂瘤组p21WAF1阳性表达率65%,分布于上皮的全层,以靠近基底层的棘细胞层和颗粒层显著,阳性指数(LI)均值为28.9%±6.7%;而正常对照组未见p21WAF1阳性表达。p21WAF1在中耳胆脂瘤上皮中的表达高于对照组(P<0.05)。③中耳胆脂瘤组TGF-β1阳性表达率90%,位于上皮全层,LI为32.3%±5.7%;在正常外耳道皮肤中阳性表达率为50%,LI为13.3%±4.9%,两组比较差异有显著性(P<0.05)。④在中耳胆脂瘤组p21WAF1与TGF-β1表达LI均值比较差异无显著性(P>0.05),p21WAF1表达LI均值与TGF-β1表达LI均值呈正相关关系(r=0.913,P<0.01)。结论:TGF-β1和p21WAF1蛋白促进胆脂瘤发生发展,并具有相关性。 Objective To study the expressions of TGF-β1 and p21WAF1 in middle ear cholesteatoma and discuses their effects on cholesteatoma. Methods The expressions of TGF-β1 and p21WAF1 were determined by immunohistochemical S-P technology and computer image analysis in 20 specimens of cholesteatoma epithelium and 10 specimens of normal external canal skin. Results (1) p21WAF1 and TGF-β1 could be detected in middle ear cholesteatoma and in normal ear canal skin. p21WAF1 was located at karyon, taking on yellow-brown pellet; TGF-β1 was located at cytoplasmic, taking on yellow-brown pellet. (2)The p21WAF1 positive rate in middle ear cholesteatoma was 65% and there were almost no positive cells in normal external ear canal skin. p21WAF1 positive cells were detected in each layers, its LI was 28.9%±6.7%. Compared with normal ear canal skin, the expression level of p21WAF1 in middle ear cholesteatoma epithelium was higher than that in normal ear canal skin (P〈0.05). (3) The TGF-β1 positive rate was 90% in middle cholesteatoma samples and 50% in normal ear canal skin. The positive cells were mostly in spine layer and granular layer in normal ear canal skin, low intensive, lightbrown, and its LI was 13.3±4.9 % in middle ear cholsteatoma epithelium, the positive cells scattered among all layers of the epithelium, and stained strongly in spine layer, high intensive, strong-brown, and its LI was 32.3%± 5.7%, there was obvious difference (P〈 0.05). (4) In cholesteatoma epithelium samples, the LI of p21WAF1 and TGF-β1 didn t have significant difference. But in cholesteatomatous tissues there was positivecorrelation between the LI average of p21WAF1 and the LI average of TGF-β1 (r = 0. 913, P 〈 0. 001) . Conclusion TGF-β1 and p21WAF1 can promote the occurrence and development of middle ear cholesteatoma, and they have positive correlation.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第4期657-660,共4页 Journal of Jilin University:Medicine Edition
基金 吉林省科学基金资助课题(200505187)
关键词 转化生长因子Β P21WAF1 中耳胆脂瘤 细胞凋亡 transforming growth factor-beta p21WAF1 cholesteatoma of middle ear apoptosis
  • 相关文献

参考文献15

  • 1Naim R, Chang RC, Anders C, et al. Up-regulation of betacatenin in external auditory canal cholesteatoma[J].Universitat HNOKlinik, 2005, 15 (5): 801-804.
  • 2杨向茹,李西秦,马敏,张莉萍,张芩娜,王建明,王斌全.基质金属蛋白酶及其抑制剂和转化生长因子-β_1在中耳胆脂瘤的表达[J].中华耳鼻咽喉科杂志,2002,37(2):121-123. 被引量:12
  • 3Shinoda H, Huang CC. Expressions of e-jun and p53 proteins in human middle ear cholesteatoma., relationship to keratinocyte proliferation, differentiation, and programmed cell death [J]. Laryngoscope, 1995, 105 (11):1232-1237.
  • 4Marenda SA, Aufdemorte TB. Localization of cytokines in cholesteatoma tissue[J].Otolaryngol Head Neck Surg, 1995, 112 (3): 359-368.
  • 5江超武,展鸿谋,王文惠,张林,金树珍,杨一兵,章宗籍.转化生长因子β1和即刻早期基因及p27在中耳胆脂瘤上皮中的表达[J].中华耳鼻咽喉科杂志,2004,39(4):211-215. 被引量:16
  • 6Margriet A, Huisman M, Emile DE, et al, Cholesteatoma epithelium is characterized by increased of Ki-67, p53, and p21, with minimal apoptosis[J].Acta Otolaryngol, 2003, 123: 337-382.
  • 7Kosa R, Yagi M, Tabe H, et al. Kinetic analysis of cell proliferation using bromodeoxyuridine labeling and in situ detection of dying ceils in the tympanic membrane and middle cholesteatoma[J].Arch Histol Cytol, 1996,59(4):339-346.
  • 8Datto MB, Yu Y, Wang XF. Functional analysis of the transforming growth factor-βresponsive elements in the WAF1/Cip1/p21 promoter[J].J Biol Chem, 1995, 270 (48):28623-28628.
  • 9Pardali K, Kurisaki A, Moren A, et al. Role of Smad protein sand transcription factor Spl inp21/Cip1 regulation by transforming growth factor-β[J].J Biol Chem, 2000, 275 (38): 29244-29256.
  • 10Naim R, Chang RC. Effect of vascular endothelial growth factor on fibroblasts from external auditory canal cholesteatoma[J].Arch Med Res, 2005, 36(5):518- 523.

二级参考文献15

  • 1李厚恩,汪磊.表皮生长因子受体在胆脂瘤的异常表达[J].耳鼻咽喉(头颈外科),1996,3(4):195-198. 被引量:3
  • 2Bujia J,ORL J Otorhinolaryngol Relat Spec,1996年,58卷,23页
  • 3Shieh TJ,Ho KY,Kuo WR,et al.Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.Kaohsiung J Med Sci,1999,15:468-474.
  • 4Shiwa M,Kojima H,Moriyama H.Expression of transferming growth factor-alpha in cholesteatoma.J Laryngol Otol,1998,112:750-774.
  • 5Tanaka Y,Kojima H,Miyazaki H,et al.Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.Laryngoscope,1999,109(7 pt 1):1102-1107.
  • 6Sastry KV,Sharma C,Mann SB,et al.Aural cholesteatoma: Role of tumor necrosis factor-a in bone destruction.Am J Otol,1999,20:158-161.
  • 7Koto A,Ohashi Y,Masamoto H,et al.Interleukin-6 and tumor necrosis factor-alpha synthesize by cholesteatoma cells affect munociliary function in the Eustachian tube.Acta Otolaryngol Suppl,1998,53:890-897.
  • 8Milewski C,Fedorowski A,Stan AC,et al.Basic fibroblast growth factor b-TGF in the perimatrix of cholesteatoma.HNO,1998,46:804-808.
  • 9Bujia J,Kim C,Holly A,et al.Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma; an analysis of protein production and gene expression.Am J Otol,1996,17:203-206.
  • 10Chae SW,Song JJ,Suh HK,et al.Expression patterns of p27 and Ki67 in cholesteatoma epithelium.Laryngoscope,2000,110:1898-1901.

共引文献31

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部